Novartis AG
Change company Symbol lookup
Select an option...
NVS Novartis AG
UBER Uber Technologies Inc
LMT Lockheed Martin Corp
SHLX Shell Midstream Partners LP
SEDG Solaredge Technologies Inc
LUNA Luna Innovations Inc
PAAS Pan American Silver Corp
FSD First Trust High Inc Long/Short Fund
GDV Gabelli Dividend & Income Trust
MNSB MainStreet Bancshares Inc
Go

Health Care : Pharmaceuticals | Large Cap Blend
Based in Switzerland
Company profile

Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Closing Price
$80.70
Day's Change
-1.21 (-1.48%)
Bid
--
Ask
--
B/A Size
--
Day's High
81.23
Day's Low
80.53
Volume
(Below Average)
Volume:
1,730,333

10-day average volume:
2,011,874
1,730,333

AppsFlyer Launches Conversion Studio to Enable Single Source Mapping for SKAdNetwork Post-install Measurement

8:00 am ET September 9, 2021 (BusinessWire) Print

AppsFlyer, the marketing measurement and experience platform, today launched Conversion Studio, a hyper-flexible solution for conversion value measurement. Conversion Studio enables marketers to master conversion values by maximizing the lifetime value measurement for post-install activity simply and effectively within the limited capacity of the SKAN framework.

"With Conversion Studio, we set out to help marketers with a challenge that has plagued them in the post iOS 14 era: the difficulty in understanding how valuable their acquired users are in the long run," said Roy Yanai, Head of Product, SKAdNetwork, AppsFlyer. "By design, SKAN limits advertisers to a single conversion value, which only captures one aspect of the user's post-install activity. With Conversion Studio, AppsFlyer is giving marketers the power to master SKAdNetwork conversions and take back control over SKAN post-install measurement with insight into the lifetime value of their users."

Conversion Studio provides marketers the ability to easily set their conversion value mapping with the flexibility to measure several metrics simultaneously. With visual cues that show the conversion value capacity and how each metric is measured, advertisers can easily fine-tune their mapping to make sure they're making the most of virtually any post-install events, including metrics such as revenue, engagement, retention and conversion. Once the conversion value mapping is housed in AppsFlyer, it can be easily shared with all the SKAN integrated partners, serving as a single-source-of-truth for SKAN measurement.

With Conversion Studio, marketers will now be able to:

Split measurement metrics. Marketers can now customize their measurement, simultaneously measuring metrics that are most important to them, such as revenue, in-app engagement, retention and more. Extend the post-install user activity timer to a 72 hour window. By extending the activity timer, marketers will be able to measure longer lifetime value. In addition, marketers have an additional option of knowing when a user was last active, which facilitates the measuring of critical aspects like retention and cohorts. Measure ranges within any specific metric. Defining flexible ranges within a specific metric enables marketers to be more efficient with the number of conversion values they implement. Measure funnels to optimize the full capacity of lifetime value. By choosing the funnel function in Conversion Studio, advertisers can efficiently measure sequential events by using fewer values, optimizing the amount of in-app events measured.

"With AppsFlyer's solution for custom conversion value mapping, we finally have the freedom in what and how we want to measure on iOS," said Michal Prokop Grno, Head of Marketing Analytics, Pixel Federation. "And all of that without the need to write a single line of code."

More information on Conversion Studio is available here: https://www.appsflyer.com/product-news/marketing-analytics/introducing-conversion-studio/

About AppsFlyer AppsFlyer helps brands make good choices for their business and their customers through innovative, privacy-preserving measurement, analytics, fraud protection, and engagement technologies. Built on the idea that brands can increase customer privacy while providing exceptional experiences, AppsFlyer empowers thousands of creators and 8,000+ technology partners to create better, more meaningful customer relationships. To learn more, visit www.appsflyer.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210909005151/en/

SOURCE: AppsFlyer">

Media Contact: 
Kenya Hayes
kenya.hayes@appsflyer.com 
(703) 589-7595
comtex tracking

COMTEX_393046475/1006/2021-09-09T08:00:02

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.